Progressive Care, Inc. (RXMD)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Progressive Care, Inc. (RXMD) trades at $2.11. Progressive Care, Inc. operates a retail pharmacy and provides long-term care solutions, specializing in anti-retroviral medications and durable medical equipment. Market cap: $13.49M, Sector: Healthcare.
Price live · AI analysis from Mar 16, 2026Analyst Coverage for RXMD: RXMD does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates RXMD against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
RXMD: 1/1 perspectives are bearish.
How is this calculated? →Progressive Care, Inc. (RXMD) Healthcare & Pipeline Overview
Progressive Care, Inc. (RXMD) is a healthcare company providing prescription pharmaceuticals and long-term care solutions in South Florida. Operating through its Pharmco, LLC subsidiary, RXMD focuses on anti-retroviral medications, durable medical equipment, and services for long-term care facilities, distinguishing itself through patient care management and specialized pharmaceutical offerings in a competitive regional market.
What Is the Investment Thesis for RXMD?
Progressive Care, Inc. presents a speculative investment opportunity within the healthcare sector, primarily focused on its specialized pharmaceutical services and long-term care solutions in South Florida. The company's negative P/E ratio of -0.89 and a negative profit margin of -29.5% indicate financial challenges. However, the 30.5% gross margin suggests potential for profitability with improved cost management and revenue scaling. Growth catalysts include expanding its service offerings within the long-term care market and leveraging its expertise in anti-retroviral medications. Key risks involve navigating the competitive pharmaceutical landscape and achieving sustainable profitability. The company's beta of -0.21 suggests lower volatility compared to the market, but this should be viewed cautiously given its OTC status and financial performance.
Based on FMP financials and quantitative analysis
RXMD Key Highlights
- Market capitalization of $13.49M indicates a micro-cap company with high growth potential but also significant risk.
- Gross margin of 30.5% demonstrates the company's ability to generate revenue above the direct cost of goods and services.
- Negative P/E ratio of -0.89 reflects current losses, suggesting the company's earnings are negative.
- Profit margin of -29.5% indicates significant expenses relative to revenue, requiring strategic cost management.
- Beta of -0.21 suggests the stock price is less volatile than the overall market, but this may not hold true given the OTC listing.
Who Are RXMD's Competitors?
RXMD is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ATBPF Antibe Therapeutics Inc. | $0.22 | -0.19% | $11.43M | 44 |
| CRPOF Ceapro Inc. | $0.17 | -13.04% | $13.31M | 46 |
| EIGRQ Eiger BioPharmaceuticals, Inc. | $8.50 | +6.25% | $12.59M | 54 |
| LXXGF LexaGene Holdings Inc. | $0.08 | +0.00% | $11.34M | 53 |
| ATAI Atai Beckley NV is a clinical-stage biopharmaceutical company focused on developing treatments for mental health disorders. The company | $4.88 | -5.97% | $1.80B | 68 |
| MEDS TRxADE HEALTH, Inc. | $7.59 | +4.55% | $13.28M | 63 |
| ONC BeOne Medicines Ltd. | $309.46 | +3.97% | $33.07B | 61 |
| NEUP Neuphoria Therapeutics Inc. | $3.44 | +1.78% | $18.59M | 60 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RXMD's Key Strengths?
- Specialized expertise in anti-retroviral medications.
- Established relationships with long-term care facilities.
- Comprehensive service offerings (pharmacy, DME, consultant services).
- Regional focus in South Florida.
What Are RXMD's Weaknesses?
- Negative profit margin and P/E ratio indicate financial instability.
- Small market capitalization limits access to capital.
- Dependence on a single geographic region.
- Limited brand recognition compared to larger competitors.
What Could Drive RXMD Stock Higher?
- Expansion of long-term care services to meet the increasing demand from skilled nursing and assisted living facilities.
- Potential partnerships with healthcare providers to broaden service offerings and market reach by Q4 2026.
- Leveraging data analytics to improve patient outcomes and enhance the value proposition for healthcare organizations.
What Are the Key Risks for RXMD?
- Financial-distress signal — its Altman Z-Score of -2.12 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-85.7%) — the business is not currently generating profit on shareholder capital.
- Intense competition from larger pharmaceutical distributors and retail chains could erode market share.
- Regulatory changes impacting pharmaceutical pricing and reimbursement could negatively affect revenue.
- Negative profit margin and P/E ratio indicate financial instability and the need for improved cost management.
- Economic downturn affecting patient spending on healthcare could reduce demand for services.
- OTC Other tier status carries inherent risks due to limited financial disclosure and regulatory oversight.
What Are the Growth Opportunities for RXMD?
- Expansion of Long-Term Care Services: Progressive Care can capitalize on the growing demand for long-term care services by expanding its offerings to skilled nursing facilities, assisted living facilities, and retirement communities. The market for long-term care is projected to reach $2.2 trillion by 2027, driven by the aging population. By offering comprehensive pharmaceutical services, consultant pharmacist services, and data analytics, Progressive Care can establish itself as a preferred partner for long-term care providers, enhancing revenue streams and market share.
- Specialization in Anti-Retroviral Medications: Progressive Care's expertise in anti-retroviral medications presents a significant growth opportunity. With the global market for HIV/AIDS drugs projected to reach $36.1 billion by 2027, the company can leverage its specialized knowledge and patient care management to attract a larger customer base. This includes expanding its reach through partnerships with HIV/AIDS clinics and community organizations, as well as offering specialized services such as medication adherence programs and patient education.
- Geographic Expansion within South Florida: While currently focused on South Florida, Progressive Care can strategically expand its geographic footprint within the region. By opening new retail pharmacy locations and establishing partnerships with healthcare providers in underserved areas, the company can tap into new markets and increase its customer base. This expansion should be data-driven, focusing on areas with high demand for prescription pharmaceuticals and long-term care services.
- Leveraging Data Analytics for Improved Patient Outcomes: Progressive Care can leverage its data analytics capabilities to improve patient outcomes and enhance its value proposition. By analyzing patient prescription histories, medication adherence data, and other relevant information, the company can identify opportunities to optimize medication regimens, reduce adverse drug events, and improve overall patient health. This data-driven approach can attract new customers and strengthen relationships with existing clients.
- Strategic Partnerships and Acquisitions: Progressive Care can pursue strategic partnerships and acquisitions to expand its service offerings and market reach. This includes partnering with other healthcare providers, such as home health agencies and specialty pharmacies, to offer a more comprehensive range of services. Additionally, the company can consider acquiring smaller pharmacies or long-term care providers to expand its geographic footprint and customer base. These strategic initiatives can accelerate growth and enhance Progressive Care's competitive position.
What Opportunities Does RXMD Have?
- Expansion of long-term care services to meet growing demand.
- Geographic expansion within South Florida.
- Leveraging data analytics to improve patient outcomes.
- Strategic partnerships and acquisitions to expand service offerings.
What Threats Does RXMD Face?
- Intense competition from larger pharmaceutical distributors and retail chains.
- Regulatory changes impacting pharmaceutical pricing and reimbursement.
- Economic downturn affecting patient spending on healthcare.
- Potential for generic competition in anti-retroviral medications.
What Are RXMD's Competitive Advantages?
- Specialization in anti-retroviral medications creates a niche market with specialized knowledge.
- Established relationships with long-term care facilities provide recurring revenue streams.
- Comprehensive service offerings, including pharmacy, DME, and consultant services, offer a competitive advantage.
- Regional focus in South Florida allows for targeted marketing and customer service.
What Does RXMD Do?
Founded in 2005 and based in Hallandale Beach, Florida, Progressive Care, Inc., through its subsidiary Pharmco, LLC, delivers prescription pharmaceuticals to individuals and institutions, primarily in South Florida. The company's core business revolves around its retail pharmacy, which specializes in anti-retroviral medications and related patient care management. In addition to pharmaceuticals, Progressive Care offers durable medical equipment (DME), including hospital beds, oxygen supplies, wheelchairs, scooters, and walkers, catering to both individual patients and long-term care facilities. Progressive Care also provides comprehensive long-term care solutions to skilled nursing facilities, assisted living facilities, retirement centers, doctors' offices, and clinics. These solutions include the supply of various prescription medications, computerized maintenance of patient prescription histories, third-party billing services, and consultant pharmacist services. The company also purchases, repackages, and dispenses prescription and non-prescription pharmaceutical products for its long-term care customers. Furthermore, Progressive Care offers home service and maintenance, defective product replacements, free home installation and instruction services, and data analytics services to support healthcare organizations. This multifaceted approach positions Progressive Care as an integrated provider within the regional healthcare landscape.
What Products and Services Does RXMD Offer?
- Operates a retail pharmacy specializing in anti-retroviral medications.
- Provides patient care management related to anti-retroviral therapies.
- Sells and rents durable medical equipment (DME) such as hospital beds and wheelchairs.
- Supplies prescription medications to long-term care facilities.
- Offers long-term care solutions to skilled nursing facilities and assisted living facilities.
- Purchases, repackages, and dispenses prescription and non-prescription pharmaceutical products.
- Provides computerized maintenance of patient prescription histories and third-party billing services.
- Offers consultant pharmacist services and data analytics to healthcare organizations.
How Does RXMD Make Money?
- Revenue from the sale of prescription pharmaceuticals, particularly anti-retroviral medications.
- Income from the sale and rental of durable medical equipment (DME).
- Fees for providing long-term care solutions and consultant pharmacist services.
- Revenue from repackaging and dispensing pharmaceutical products to long-term care customers.
What Industry Does RXMD Operate In?
Progressive Care, Inc. operates within the medical pharmaceuticals industry, which is characterized by intense competition and regulatory scrutiny. The market is driven by an aging population and increasing demand for prescription medications and long-term care services. The company competes with larger pharmaceutical distributors and retail pharmacy chains, as well as smaller regional players. Market trends include a growing emphasis on personalized medicine, telehealth, and value-based care. Progressive Care's focus on anti-retroviral medications and long-term care solutions positions it within a niche segment of the broader healthcare market.
Who Are RXMD's Key Customers?
- Individuals requiring prescription pharmaceuticals, especially anti-retroviral medications.
- Long-term care facilities, including skilled nursing facilities and assisted living facilities.
- Hospitals, clinics, and doctors' offices.
- Patients requiring durable medical equipment (DME).
How Progressive Care, Inc. Is Valued
Progressive Care, Inc. carries a market capitalization of $13.49M, placing it in the micro-cap category.
Company Profile
Progressive Care, Inc. operates in the Medical - Pharmaceuticals industry within the Healthcare sector. It is headquartered in Hallandale Beach, US. The company is led by CEO Charles M. Fernandez. RXMD has traded publicly since 2010.
ROE -86%Key Financial Metrics
Return on equity for Progressive Care, Inc. stands at -85.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -36.3%, showing how much profit it generates from its asset base. Its free cash flow yield is 0.8%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.72 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -112.0%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 4/9Financial Health
Progressive Care, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -2.12 places it in the distress zone, a signal of elevated financial risk.
Net buyingInsider Activity
The most recent 12 insider filings for Progressive Care, Inc. break down as 4 sales and 8 purchases. On net that is roughly 1.2M shares acquired (about $1.6M) — insiders putting money in tends to read as conviction.
RXMD Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Specialized expertise in anti-retroviral medications.
- Established relationships with long-term care facilities.
- Comprehensive service offerings (pharmacy, DME, consultant services).
- Regional focus in South Florida.
Bear Case
- Negative profit margin and P/E ratio indicate financial instability.
- Small market capitalization limits access to capital.
- Dependence on a single geographic region.
- Limited brand recognition compared to larger competitors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
RXMD Latest News
No recent news available for RXMD.
RXMD Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for RXMD.
Price Targets
Wall Street price target analysis for RXMD.
RXMD MoonshotScore
What does this score mean?
The MoonshotScore rates RXMD's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Charles M. Fernandez
CEO
Charles M. Fernandez serves as the CEO of Progressive Care, Inc., leading the company's strategic direction and overseeing its operations. His background includes extensive experience in healthcare management and pharmaceutical services. Fernandez is responsible for managing the company's 143 employees and driving its growth initiatives. He has a proven track record of building and scaling healthcare businesses, with a focus on delivering high-quality patient care and innovative solutions.
Track Record: Under Charles M. Fernandez's leadership, Progressive Care, Inc. has focused on expanding its long-term care solutions and strengthening its position in the anti-retroviral medication market. He has overseen the implementation of new technologies and data analytics to improve patient outcomes and operational efficiency. Fernandez has also been instrumental in forging strategic partnerships with healthcare providers and long-term care facilities to expand the company's reach.
RXMD OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Progressive Care, Inc. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial disclosure and may be subject to greater regulatory scrutiny. Investing in OTC Other stocks carries significant risks due to the potential for fraud, lack of liquidity, and limited information available to investors. This tier is generally reserved for companies with distressed financials, shell corporations, or those that are non-reporting.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the risk of investing due to lack of transparency.
- Low trading volume and wide bid-ask spreads can lead to price volatility and difficulty in executing trades.
- Potential for fraud and manipulation is higher in the OTC market due to less stringent regulatory oversight.
- OTC Other tier status indicates the company may not meet minimum financial standards.
- Dependence on a single geographic region (South Florida) increases vulnerability to local market conditions.
- Verify the company's financial statements and SEC filings (if available).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's cash flow and ability to meet its financial obligations.
- Review the company's legal and regulatory compliance.
- Check for any red flags, such as pending lawsuits or regulatory investigations.
- Consult with a financial advisor before investing.
- The company has been in operation since 2005, indicating some level of stability.
- Progressive Care, Inc. has a physical presence in Hallandale Beach, Florida.
- The company provides essential healthcare services, including prescription pharmaceuticals and DME.
- The company has 143 employees, suggesting a real operational business.
What Investors Ask About Progressive Care, Inc. (RXMD) — Healthcare
What does Progressive Care, Inc. do?
Progressive Care, Inc., through its subsidiary Pharmco, LLC, operates as a retail pharmacy and provides long-term care solutions, primarily in South Florida. The company specializes in anti-retroviral medications and related patient care management, as well as the sale and rental of durable medical equipment (DME). It also supplies prescription medications and consultant pharmacist services to long-term care facilities, offering a comprehensive suite of services to individuals and institutions within the healthcare sector.
What do analysts say about RXMD stock?
As of March 16, 2026, formal analyst ratings for RXMD are limited due to its OTC listing and small market capitalization. Investors should conduct their own due diligence and consider the company's financial performance, growth opportunities, and risk factors before making any investment decisions. The company's negative P/E ratio and profit margin warrant careful consideration, as does its OTC Other tier status.
What are the main risks for RXMD?
The main risks for Progressive Care, Inc. include intense competition from larger pharmaceutical distributors and retail chains, regulatory changes impacting pharmaceutical pricing and reimbursement, and the company's financial instability as indicated by its negative profit margin and P/E ratio. Additionally, the OTC Other tier status carries inherent risks due to limited financial disclosure and regulatory oversight. Economic downturns could also affect patient spending on healthcare, reducing demand for the company's services.
How does Progressive Care, Inc. manage its supply chain?
Progressive Care, Inc. manages its supply chain by purchasing prescription and non-prescription pharmaceutical products, repackaging them, and dispensing them to its long-term care customers. The company also sources durable medical equipment (DME) from various suppliers. Effective supply chain management is crucial for ensuring timely delivery of medications and equipment, maintaining product quality, and controlling costs. The company's ability to negotiate favorable pricing with suppliers and manage inventory levels is essential for its profitability and competitiveness.
What is Progressive Care, Inc.'s strategy for growth in the competitive pharmaceutical market?
Progressive Care, Inc.'s strategy for growth in the competitive pharmaceutical market involves focusing on specialized services, such as anti-retroviral medications and long-term care solutions. By specializing in these niche areas, the company can differentiate itself from larger competitors and attract a specific customer base. Additionally, the company aims to expand its geographic reach within South Florida, leverage data analytics to improve patient outcomes, and pursue strategic partnerships and acquisitions to broaden its service offerings and market reach.
What are the key factors to evaluate for RXMD?
Evaluate RXMD on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does RXMD data refresh on this page?
RXMD prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven RXMD's recent stock price performance?
Progressive Care, Inc. (RXMD) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized expertise in anti-retroviral medications. See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited analyst coverage and financial data available for RXMD due to its OTC listing.
- OTC market investments carry higher risk than exchange-listed stocks.
- Financial data based on the most recently available information.